For a long time, the study of the brain has largely focused on neuronal cells. However, neurons develop and interact closely together in space and time with the neuroglia, represented by astrocytes, microglia and oligodendrocytes. Glia are further highly conserved throughout evolution and are, except for the cerebellum, the most abundant cell type in almost all subregions of the mammalian brain. This suggests important functional roles for glia and their interaction with neurons in both brain physiology and pathology. Many models for studying neurons and glia have been based on rodents, where lines of identical animals are available and genetic manipulations are easily accomplished. However, model validity, compared to the human brain, remains to be confirmed. Indeed, recent studies revealed several important differences between rodent and human neurons and glia in terms of morphology, receptor composition, inflammatory responses and released mediators.
Despite these differences, rodent models have helped to understand the roles of glial cells in neuronal pathologies that include Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, glioblastoma, autism and psychiatric disorders. Hopes that animal models would lead to new medicaments have however often been muted by poor progress from successful pre-clinical tests to an absence of efficacy in clinical trials.
In order to bridge this gap between animal and human studies, three classes of brain surrogate offer researchers a way to investigate how the living human brain works, without the need for procedures in people: (1) organoids, (2) ex vivo brain tissues and (3) chimaeras. The main source of human fresh brain tissue is nowadays from operations on patients with conditions including epilepsies and brain tumors. The possibility to obtain these fresh tissues is not rare, considering the high number of brain surgeries per year.
Moreover, technological advances, including imaging and the techniques used to preserve the functional properties of brain tissues in the lab, could make these approaches considerably more powerful for the investigation of neuron-glia-interaction across various pathological conditions.
This Research Topic will welcome papers using or discussing the use of human brain tissue, post mortem or fresh, for organoids, ex vivo and chimaeras studies that pertain to neuronal and glial cell function and interaction in neuro-pathological contexts.
The aim is to sensitize researchers to consider and integrate, in their research work on neurons and glia, the use of human brain tissue. This effort could tremendously improve our understanding of brain pathology and reveal unexpected differences between human and animals brain function.
Keywords:
Human brain, neuronal circuit, glial cells, brain physio-pathology, research methodologies, ethics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
For a long time, the study of the brain has largely focused on neuronal cells. However, neurons develop and interact closely together in space and time with the neuroglia, represented by astrocytes, microglia and oligodendrocytes. Glia are further highly conserved throughout evolution and are, except for the cerebellum, the most abundant cell type in almost all subregions of the mammalian brain. This suggests important functional roles for glia and their interaction with neurons in both brain physiology and pathology. Many models for studying neurons and glia have been based on rodents, where lines of identical animals are available and genetic manipulations are easily accomplished. However, model validity, compared to the human brain, remains to be confirmed. Indeed, recent studies revealed several important differences between rodent and human neurons and glia in terms of morphology, receptor composition, inflammatory responses and released mediators.
Despite these differences, rodent models have helped to understand the roles of glial cells in neuronal pathologies that include Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, glioblastoma, autism and psychiatric disorders. Hopes that animal models would lead to new medicaments have however often been muted by poor progress from successful pre-clinical tests to an absence of efficacy in clinical trials.
In order to bridge this gap between animal and human studies, three classes of brain surrogate offer researchers a way to investigate how the living human brain works, without the need for procedures in people: (1) organoids, (2) ex vivo brain tissues and (3) chimaeras. The main source of human fresh brain tissue is nowadays from operations on patients with conditions including epilepsies and brain tumors. The possibility to obtain these fresh tissues is not rare, considering the high number of brain surgeries per year.
Moreover, technological advances, including imaging and the techniques used to preserve the functional properties of brain tissues in the lab, could make these approaches considerably more powerful for the investigation of neuron-glia-interaction across various pathological conditions.
This Research Topic will welcome papers using or discussing the use of human brain tissue, post mortem or fresh, for organoids, ex vivo and chimaeras studies that pertain to neuronal and glial cell function and interaction in neuro-pathological contexts.
The aim is to sensitize researchers to consider and integrate, in their research work on neurons and glia, the use of human brain tissue. This effort could tremendously improve our understanding of brain pathology and reveal unexpected differences between human and animals brain function.
Keywords:
Human brain, neuronal circuit, glial cells, brain physio-pathology, research methodologies, ethics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.